GenoLogics, the Victoria, BC-based developer of software for biologists and physicians, has raised another $1 million of equity financing out of a round that could be worth $1.5 million, according to a regulatory filing. GenoLogics previously raised $5 million in February 2009 from OVP Venture Partners, Yaletown Venture Partners, and GrowthWorks Capital. We profiled the company’s strategy, to better piece together genomic data with electronic health records, back in May 2009.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
